HR. 1406In Committee
Lung Cancer Screening and Prevention Act of 2025
Authorize Medicare coverage for additional FDA-approved lung cancer screening tests without requiring a USPSTF recommendation, and direct CMS to set coverage and payment limits
Plain-English overview
What this bill does
Authorize Medicare coverage for additional FDA-approved lung cancer screening tests without requiring a USPSTF recommendation, and direct CMS to set coverage and payment limits
Key points
- Authorize Medicare screening coverage
- Direct CMS payment limits
Current status
Where it stands
Status
In Committee
Latest action
2025-02-18 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related context
Topics and policy areas
undefinedCancerCardiovascular and respiratory healthHealthHealth care coverage and accessHealth promotion and preventive careMedical tests and diagnostic methodsMedicare